CTLT insider transaction filings
Catalent, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-12-18. Screen CTLT transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CTLT between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — Catalent, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-12-18 | 4 | Gennadios Aristippos — Group Pres. Pharma & Consumer | Disposition to issuer (D): 113,724 · Grant/award (A): 21,562 @ $0 · Disposition to issuer (D): 21,562 | EDGAR |
| 2024-12-18 | 4 | McErlane David — Group President, Biologics | Disposition to issuer (D): 36,304 · Grant/award (A): 11,426 @ $0 · Disposition to issuer (D): 11,426 · Disposition to issuer (D): 14,740 (derivative) | EDGAR |
| 2024-12-18 | 4 | Hatzfeld Michael — Chief Accounting Officer | Disposition to issuer (D): 13,532 · Grant/award (A): 3,144 @ $0 · Disposition to issuer (D): 3,144 | EDGAR |
| 2024-12-18 | 4 | Gunther Scott — SVP, Quality & Reg. Affairs | Disposition to issuer (D): 39,635 · Grant/award (A): 12,938 @ $0 · Disposition to issuer (D): 12,938 | EDGAR |
| 2024-12-18 | 4 | Ferraro Joseph Anthony — SVP, General Counsel, CCO | Disposition to issuer (D): 23,967 · Grant/award (A): 14,265 @ $0 · Disposition to issuer (D): 14,265 | EDGAR |
| 2024-12-18 | 4 | Ryan Michelle R — Director | Disposition to issuer (D): 10,835 | EDGAR |
| 2024-12-18 | 4 | Okey Stephanie — Director | Disposition to issuer (D): 12,635 | EDGAR |
| 2024-12-18 | 4 | Barg Steven — Director | Disposition to issuer (D): 12,374 | EDGAR |
| 2024-12-18 | 4 | Barber Michael J — Director | Disposition to issuer (D): 18,052 | EDGAR |
| 2024-12-18 | 4 | Maselli Alessandro — President & CEO, Director | Disposition to issuer (D): 177,521 · Grant/award (A): 113,224 @ $0 · Disposition to issuer (D): 113,224 · Disposition to issuer (D): 11,093 (derivative) · Disposition to issuer (D): 10,375 (derivative) · Disposition to issuer (D): 10,523 (derivative) · +5 more | EDGAR |
| 2024-12-18 | 4 | Hopson Ricky — Pres. BioProduct Delivery, CoS | Disposition to issuer (D): 29,974 · Grant/award (A): 10,722 @ $0 · Disposition to issuer (D): 10,722 · Disposition to issuer (D): 1,550 (derivative) · Disposition to issuer (D): 2,622 (derivative) · Disposition to issuer (D): 3,650 (derivative) · +4 more | EDGAR |
| 2024-12-18 | 4 | Evoli Lisa — SVP, Chief HR Officer | Disposition to issuer (D): 39,366 · Grant/award (A): 12,032 @ $0 · Disposition to issuer (D): 12,032 · Disposition to issuer (D): 14,225 (derivative) | EDGAR |
| 2024-12-18 | 4 | Masanovich Matti — SVP, Chief Financial Officer | Disposition to issuer (D): 76,475 · Grant/award (A): 71,691 @ $0 · Disposition to issuer (D): 71,691 · Disposition to issuer (D): 81,082 (derivative) | EDGAR |
| 2024-12-18 | 4 | CARROLL J MARTIN — Director | Disposition to issuer (D): 32,734 | EDGAR |
| 2024-12-18 | 4 | GREISCH JOHN J — Executive Chair, Director | Disposition to issuer (D): 79,932 · Disposition to issuer (D): 34,000 · Grant/award (A): 33,530 @ $0 · Disposition to issuer (D): 33,530 · Disposition to issuer (D): 127,096 (derivative) | EDGAR |
| 2024-12-18 | 4 | LUCIER GREGORY T — Director | Disposition to issuer (D): 36,914 | EDGAR |
| 2024-12-18 | 4 | MOREL DONALD E JR — Director | Disposition to issuer (D): 70,118 | EDGAR |
| 2024-12-18 | 4 | DAMELIO FRANK A — Director | Disposition to issuer (D): 12,635 | EDGAR |
| 2024-12-18 | 4 | CLASSON ROLF A — Director | Disposition to issuer (D): 47,984 | EDGAR |
| 2024-12-18 | 4 | STAHL JACK L — Director | Disposition to issuer (D): 47,984 | EDGAR |
| 2024-11-14 | 4 | Ryan Michelle R — Director | Sale (S): 2,800 @ $59.70 | EDGAR |
| 2024-11-01 | 4 | Barg Steven — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | Ryan Michelle R — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | Okey Stephanie — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | Barber Michael J — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | CARROLL J MARTIN — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | LUCIER GREGORY T — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | MOREL DONALD E JR — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | DAMELIO FRANK A — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | CLASSON ROLF A — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-11-01 | 4 | STAHL JACK L — Director | Grant/award (A): 4,663 @ $0 | EDGAR |
| 2024-10-21 | 4 | Ferraro Joseph Anthony — SVP, General Counsel, CCO | Sale (S): 320 @ $59.97 | EDGAR |
| 2024-09-27 | 4 | McErlane David — Group President, Biologics | Sale (S): 1,994 @ $59.97 | EDGAR |
| 2024-08-05 | 4 | Hopson Ricky — Pres. BioProduct Delivery, CoS | Sale (S): 662 @ $59.56 | EDGAR |
| 2024-08-05 | 4 | Gunther Scott — SVP, Quality & Reg. Affairs | Sale (S): 666 @ $59.55 | EDGAR |
| 2024-08-05 | 4 | Ferraro Joseph Anthony — SVP, General Counsel, CCO | Sale (S): 608 @ $59.58 | EDGAR |
| 2024-08-05 | 4 | Evoli Lisa — SVP, Chief HR Officer | Sale (S): 3,859 @ $59.67 | EDGAR |
| 2024-08-05 | 4 | Gennadios Aristippos — Group Pres. Pharma & Consumer | Sale (S): 1,169 @ $59.55 | EDGAR |
| 2024-07-30 | 4 | Hatzfeld Michael — Chief Accounting Officer | Grant/award (A): 5,624 @ $0 | EDGAR |
| 2024-07-30 | 4 | McErlane David — Group President, Biologics | Grant/award (A): 18,746 @ $0 | EDGAR |
| 2024-07-30 | 4 | Ferraro Joseph Anthony — SVP, General Counsel, CCO | Grant/award (A): 17,042 @ $0 | EDGAR |
| 2024-07-30 | 4 | Evoli Lisa — SVP, Chief HR Officer | Grant/award (A): 15,338 @ $0 | EDGAR |
| 2024-07-30 | 4 | Maselli Alessandro — President & CEO, Director | Grant/award (A): 98,671 @ $0 · Sale (S): 9,088 @ $58.76 | EDGAR |
| 2024-07-30 | 4 | Hopson Ricky — Pres. BioProduct Delivery, CoS | Grant/award (A): 10,225 @ $0 · Sale (S): 206 @ $58.67 | EDGAR |
| 2024-07-30 | 4 | Gunther Scott — SVP, Quality & Reg. Affairs | Grant/award (A): 11,078 @ $0 · Sale (S): 283 @ $58.69 | EDGAR |
| 2024-07-30 | 4 | Gennadios Aristippos — Group Pres. Pharma & Consumer | Grant/award (A): 18,746 @ $0 · Sale (S): 349 @ $58.70 | EDGAR |
| 2024-07-30 | 4 | Masanovich Matti — SVP, Chief Financial Officer | Grant/award (A): 42,604 @ $0 | EDGAR |
| 2024-07-30 | 4 | GREISCH JOHN J — Executive Chair, Director | Grant/award (A): 63,736 @ $0 | EDGAR |
| 2024-07-10 | 4 | Masanovich Matti — SVP, Chief Financial Officer | Sale (S): 2,993 @ $56.74 | EDGAR |
| 2024-06-05 | 4 | Hopson Ricky — Pres. BioProduct Delivery, CoS | Sale (S): 1,401 @ $54.26 | EDGAR |
Recent 8-K events — Catalent, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-12-18 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CTLT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →